# The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression

> **NCT00125957** · PHASE3 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 32 (actual)

## Conditions studied

- Depression
- Major Depressive Disorder
- Unipolar Depression

## Interventions

- **DRUG:** Wellbutrin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00125957
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-01
- **Final completion:** 2011-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125957, "The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00125957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*